Pictet Asset Management Sa Roivant Sciences Ltd. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pictet Asset Management Sa holds 38,079 shares of ROIV stock, worth $619,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,079
Previous 30,915
23.17%
Holding current value
$619,164
Previous $228,000
67.98%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$975 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$727 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$575 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$557 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.5B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...